Symeres acquires Massachusetts-based Organix Inc., adding lipids expertise and creating a strategic foothold in the US market
We are happy and proud to announce the acquisition of Organix, a US-based provider of high-quality […]
Symeres’ daughter company Admescope welcomes Leah Haydock
Admescope, part of the Symeres family, has provided tailor-made ADME-Tox services to biotech and pharma companies […]
Opening Innovation Centre Chemistry & Engineering
The Innovation Centre Chemistry & Engineering was opened on March 24th in Groningen. As one of the […]
Turning waste into sustainable scaffolds for synthesis
Symeres’ high-throughput SymeGold library features compounds with a high degree of three-dimensionality.
Symeres welcomes Dr. André de Vries
At Symeres, we’re always looking to support our clients with novel and innovative ideas. Dr. André de Vries joined our ranks as of January 1, 2022.
Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II
In 2016, Stefan Krauss and Jo Waaler (University Hospital of Oslo, Norway) approached Symeres to optimize […]
Chiralix, a Symeres company
Richard Baauw joined Symeres in 2017, along with his company Chiralix. Chiralix focused on the synthesis of optically active compounds.
C&ENs 10 Start-Ups to Watch
This week, the 2021 Chemical & Engineering News list of ‘10 Start-Ups to Watch’ came out. […]
Expanding the toolbox: Resolving racemates
Symeres has quite a legacy when it comes to university collaborations. For many years, we’ve been […]
